We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Legislators Introduce Follow-On Biologics Bill

Law360 (March 14, 2008, 12:00 AM EDT) -- A bill proposed by two members of the U.S. House of Representatives to create a pathway for generic or follow-on biologic drugs similar to the abbreviated new drug application for conventional generic drugs has, unsurprisingly, divided the pharmaceutical industry.

Reps. Anna G. Eshoo (D-Calif.) and Joe Barton (R-Texas) introduced the Pathway for Biosimilars Act, (H.R. 5629) on Thursday. The bill would create a regulatory pathway for U.S. Food and Drug Administration approval of follow-on biologics.

Eschoo said the bill would allow the FDA to decide whether...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.